Skip to content

Clinical trials

Phase 3 Respiratory Tract Infections trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Infections Phase: Phase 3 Country / region: Germany Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20122
20132
20161
20171
20181
20202
20211
20222
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting4
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Insmed Incorporated2
Medicago2
Pfizer2
Serum Life Science Europe GmbH2
AstraZeneca1
Biotest1
InQpharm Group1
Janssen Research & Development, LLC1
Novartis1
Pierre Fabre Medicament1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Infections15
COVID-196
Virus Diseases5
Infections4
Lung Diseases4
Pneumonia4
RNA Virus Infections4
Respiratory Tract Diseases4
Coronavirus Infections3
Influenza, Human3

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.